Frequently Asked Questions

The Regenokine® Program in one form or another has been in clinical use for more than 10 years. It is estimated that more than 10,000 patients have experienced the Regenokine® Program. To date, most patients have been in Europe, but its use is spreading quickly in the US. We are constantly evolving the program to incorporate the leading practices of medicine.

Only you and your Regenokine® Program Doctor can ultimately decide if the program is right for you. No treatment or program can guarantee pain-free results, and individuals respond differently based on the cause and duration of pain, disease, and natural variation in response to treatments.

That said, experience shows that the good candidates have tended to be those whose pain stems from mild to moderate osteoarthritis in affected joints and back or from a variety of sports-related joint injuries. End-stage osteoarthritis is typically an indication for surgery including joint replacement.

Medical history, physical examination, symptoms, and imaging determine if you are a good candidate for the Regenokine® Program. This evaluation can be performed by your Regenokine® Program Doctor.

Factors influencing the number of office visits could include, but are not limited to, the severity of the condition, the degree of pain, comorbidities (pre-existing illnesses), etc. It’s important to consult with your doctor for a final determination.

Many patients report no significant disruption to their daily lifestyle. It depends on the individual case.
Consult with your doctor.

No, the Regenokine® Program is not PRP or stem cell. Nor are PRP or stem cell part of the Program.

Adverse events reported by patients and/or their doctors after injection therapy with ACS had a combined frequency of <1% of total injections in Europe from 2012 through 2019. The most frequently reported adverse events were painful injection sites, local inflammatory reactions (swelling, heat, pain), and flu‑like symptoms. Injections with ACS have also been studied clinically for safety and effectiveness. Across 5 randomized controlled studies, ACS injections had a safety profile comparable to placebo and other therapeutic modalities used in the control groups.

Patients of almost every age and from all walks of life have experienced the Regenokine® Program. Additionally, a long line of professional athletes from the NBA, NFL, MLB, WNBA, MLS, PGA, UFC, NHL, international soccer leagues, skiers,  Olympic teams (including the US Team), professional ballet dancers as well as weekend warriors has been treated with the Regenokine® Program. Note: Please remember, that ultimately any questions concerning your treatment options, experiences, and results with the Regenokine® Program are based on individual circumstances and should be assessed in direct consultation and collaboration with your Doctor.

The US FDA regulates medical devices and drugs. The Regenokine® Program is a treatment philosophy that is not subject to FDA regulation. We only connect you to doctors who have met all state licensing requirements for the practice of medicine, most with advanced board certification in relevant specialties. If you have questions, please be sure to ask your Regenokine® Program Doctor!